7:00 8:00 9:00 10:00 11:00 11:20 12:00 12:50 13:00 14:00 14:40 15:00 16:00 16:10 16:30 17:00 18:00. Luncheon Seminar 1 Bayer Yakuhin, Ltd.

Transcription

1 Thursday, September 14 7:00 8:00 9:00 10:00 11:00 11:20 12:00 12:50 13:00 14:00 14:40 15:00 16:00 16:10 16:30 17:00 18:00 Invited Symposium 1AF1 Driver Mapping and Ablation for Atrial Fibrillation Luncheon Seminar 1 Bayer Yakuhin, Invited Symposium 2AF2 Anatomical Understanding and Issues of Heart for Catheter Ablation for Atrial Fibrillation Invited Symposium 3AF3 Management of Atria Tachycardia after Ablation for Atrial Fibrillation Invited Symposium 4SCD1 Selection for Primary Prevention of Sudden Cardiac Death, ICD Versus S-ICD Invited Symposium 6Pharmacological Therapy1 Pharmacological Approach to Improve Survival in Patients with Cardiac Arrest Invited Symposium 9Basic/Genetic1 Remodeling and Arrhythmias Oral PresentationJO2 AF1 Oral PresentationJO3 Pharm1 Luncheon Seminar 2 Luncheon Seminar 3 Bristol-Myers Squibb Pfizer JAPAN Inc. Teatime Seminar 1 Thrombosis Research Institute 12:40 Teatime Seminar 2 Luncheon Seminar 4 Cook Japan, Inc. Invited Symposium 7Pharmacological Therapy2 Selective Usage of Direct Oral Anticoagulants on the Basis of Characteristics in Patients with Non-Valvular Atrial Fibrillation Invited Symposium 10Basic/Genetic2 Brugada Syndrome: Up-to-Date Invited Symposium 121 Controversies in Lead Extraction: (1) SVC Approach vs IVC Approach, (2) Laser Sheath Technique vs Non-Laser Technique Oral Presentation 4 Basic1 16:20 15:40 15:50 16:50 Oral Presentation 5 CRT1 Invited Symposium 5SCD2 Update of Primary ICD Indication for Idiopathic VF (Brugada and J Wave Syndrome) Invited Symposium 8AF4 Strategy of Catheter Ablation for Persistent Atrial Fibrillation Oral PresentationJO1 SVT1 Invited Symposium 11Pediatric1 Therapeutic Strategy for Post Operative Congenital Heart Disease Invited Symposium 132 Nightmares of Lead Extraction Oral Presentation 6 AF2 417 Invited Symposium 14Syncope1 Diagnosis and Treatment for Syncope Using Recently Developed and Emerging Luncheon Seminar 5 Stereotaxis, Inc. Invited Symposium 15Noninvasive1 Noninvasive Risk Assessment for Predicting Serious Tachyarrhythmia Invited Symposium 16Syncope2 Driver's License Including Pilot and Syncope Current Status in Each County Sponsored Academia Session 1 Seminar 1 Seminar 2 Co. Nice Invited Symposium 18SCD4 Prevention of Sudden Cardiac Death: Guidelines vs. Real World Medicine Invited Symposium 21Surgery1 Ventricular Tachycardia Oral Presentation 7 Pharm1 Oral Presentation 8 VT1 Oral Presentation 10 AF1 Invited Symposium 193 Prevention of AF in Patients Role of Pacing Sites and Algorithm 16:20 Invited Symposium 17SCD3 Role of Catheter Ablation to Prevent SCD in Patients with Brugada Syndrome, J Wave Syndrome and CPVT Oral Presentation 9 Brady1 Sponsored Academia Session 2 Invited Symposium 204 Upgrade to CRT: Indication, Efficacy and Unsolved Problem Invited Symposium 22Surgery2 Surgery Related Unsolved and Upcoming Issues Invited Symposium 23AF5 Atrial Fibrillation and Stroke Invited Symposium 24AF6 Atrial Fibrillation as a 'Systemic Disease' 512 Invited Symposium 25VT1 Revisit of Brugada Syndrome (BS): From Genetics to Catheter AblationConduction Abnormality vs. Repolarization Abnormality General Symposium 1 Ablation Strategy of Long-Standing Persistent Afib Invited Symposium 29SVT1 AVNRT Revisited Invited Symposium 26VT2 How to Manage Failed Ablation VT Cases Invited Symposium 28Basic/Genetic3 AF#1-Basic Research Invited Symposium 30SVT2 Nightmare Cases: SVT Invited Symposium 27VT3 VT Ablation in Non-Ischemic Unusual Substrate Invited Symposium 31SVT3 Catheter Ablation of Supraventicular Tachycardia Japanese SessionChinese Session

2 Friday, September 15 7:00 8:00 8:30 9:00 10:00 11:00 12:00 12:40 13:00 13:30 14:00 15:00 15:15 16:00 16:15 16:30 17:00 18:00 Opening Remarks Core Curriculum Session 1 Invited Symposium 32AF7 Cryoballoon Ablation for Atrial Fibrillation Luncheon Seminar 6 General Symposium 2 Approach to CRT Non-Responders Kazuo Yamada Invited Lecture Molecular Genetics Have Opened a New Era for Arrhythmia Research, but AlsoPandoras Box? Core Curriculum Session 2 Can Afib Ablation Reduce Embolic Strokes and Improve Prognosis? Invited Symposium 33Basic/Genetic4 APHRSHRS Joint Session Arrhythmias and Cardiomyopathy (DCM, HCM, Lead Management and Extraction others) Luncheon Seminar 7 Teatime Seminar 3 JHRSEHRA Joint Session Novel Diagnostic and Therapeutic Strategies of Atrial Fibrillation APHRSEHRA Joint Session Ventricular Arrhythmias in Non-Ischemic Cardiomyopathy: Refining the Old and Emergence of New Substrates Morning Seminar 1 Oral Presentation 14 SCD-1 JHRSAPHRS Joint Session AF Screening for Prevention of Stroke in the Asia Pacific Region General Symposium 3 Inherited Arrhythmia Syndromes: From Bench to Bedside General Symposium 4 Risk Assessment and Prevention of Sudden Cardiac Death Oral Presentation 15 Inherit-1 Invited Symposium 34Pharmacological Therapy3 Periprocedual Antiarrhythmic Drug Use in Patients Undergoing Catheter Ablation for Atrial Fibrillation Invited Symposium 38Basic/Genetic5 Circadian Rhythm/Autonomic Nervous System and Arrhythmias Invited Symposium 415 Management of Non-Responder to CRT Invited Symposium 43Others Radiation Exposure During Catheter Ablation 9:30 10:30 Oral Presentation 16 Basic-2 Luncheon Seminar 8 Luncheon Seminar 9 Luncheon Seminar 10 Luncheon Seminar 11 Nihon Kohden Corporation Invited Symposium 35Pharmacological Therapy4 Specific Pharmacological Therapy for Inherited Arrhythmias Teatime Seminar 4 St. Jude Medical Japan Co., Ltd Lecture 1 Expert Teaching Invited Symposium 44SCD3 Best Strategy of Prevention of Sudden Cardiac Arrest due to Coronary Vasospasm Mandarin Case Competition 1 St. Jude Medical Japan Co., Ltd Oral PresentationJO11 Tachy-1 Oral Presentation 17 VT-9 14:40 Invited Symposium 36AF8 New Mapping Systems for Atrial Fibrillation Invited Symposium 39Basic/Genetic6 ARVC: Up-to-Date Clinical Characteristics and Management of Electrical Storm Focusing on the Disease Specificity Invited Symposium 45SCD6 Role of Wearable Cardioverter Defibrillator in SCD prevention Mandarin Case Competition 2 St. Jude Medical Japan Co., Ltd 15:40 15:50 16:50 Oral PresentationJO12 AF-2 14:50 Oral Presentation 18 Oral PresentationJO13 Pharm-2 Oral Presentation 19 Basic-3 Invited Symposium 37AF9 Risk and Complication of AF Ablation Invited Symposium 40Basic/Genetic7 Cutting Edge of Genomic Research: GWAS, NGS, and Others Invited Symposium 426 Left Atrial Appendage Intervention for Thromboembolic Complications in Atrial Fibrillation: Endocardial, Epicardial or Surgical Approach Invited Symposium 46Pediatric2 Pediatric ICD/CRT Oral Presentation 20 Monitoring Oral Presentation 21 Pharm-2 Oral Presentation 27 AF-3 Oral Presentation 22 Pediatric-1 Oral Presentation 28 CRT-2 Oral Presentation 23 VT-3 Oral Presentation 29 ImpExt Featured Research Session 1 Basic Featured Research Session 2 Oral Presentation 24 Pharm-3 Oral Presentation 30 Tachy-1 Oral Presentation 25 Syncope-1 Oral Presentation 31 Brady-3 Oral Presentation 26 CHF-1 17:05 Oral Presentation 32 AF-7 18:20 Nice 512 Morning Seminar 2 St. Jude Medical Japan Oral Presentation 33 VT-2 Seminar 3 Boston Scientific Sponsored Academia Session 3 Seminar 4 Oral Presentation 34 SVT-1 Invited Symposium 47VT4 Substrate Mapping for Sustained Monomorphic VT in Structural Heart Disease Invited Symposium 52Syncope3 Diagnosis and Management of Idiopathic Paroxysmal AV Block in Syncope ATP Sensitive AV Block Allied Professional Program 1 EP Study and Catheter Ablation-1 2 Oral Presentation 39 AF-4 1 General Symposium 6 Role of New Defibrillation s Seminar 5 Johnson & Johnson Sponsored Academia Session 4 Oral Presentation 35 SVT-2 Invited Symposium 48VT5 Ablation and Surgery of Outflow Tract VT/VPC Invited Sumposium 53Noninvasive3 Noninvasive Risk Stratification for Sudden Cardiac Death in J Wave Syndrome Allied Professional Program 2-1 Oral Presentation 40 AF-5 2 IInvited Symposium 57 Basic/Genetic8 Genetics of IVF and SCD MRII / / Luncheon Seminar 12 St. Jude Medical Japan Co., Luncheon Seminar 13 Luncheon Seminar 14 St. Jude Medical Japan Luncheon Seminar 15 Bayer Yakuhin, Seminar 6 Japan Lifeline Teatime Seminar 5 Oral Presentation 36 SVT-3 Seminar 7 Invited Symposium 49VT6 Fibrosis and Ventricular Tachycardia/Fibrillation Teatime Seminar 6 JAB JAB Lecture 3 Diagnosis and Treatment of Syncope Seminar 8 Sponsored Academia Session 5 Oral Presentation 37 SCD-2 Invited Symposium 50VT7 Chicken or Egg?: PVC Induced Low LVEF or Low EF Causing PVCs? General Symposium 5 Fighting with 'Refractory Ventricular Arrhythmia' Oral Presentation 41 VT-4 1 JHRS 5 Clinical Research/Teaching Case Reports 14:40 16:10 Oral Presentation 43 Allied-1 Invited Symposium 557 Role of S-ICD in Primary Prevention of SCD Oral Presentation 42 Brady-2 2 Great Debate 1 What is the Best Strategy of Persistnet Afib Ablation: Signal Guided, Linear Ablation, Rotor Guided or Voltage Guided? Oral Presentation 44 Allied-2 Seminar 9 Abbott Sponsored Academia Session 6 Oral Presentation 38 AF-6 Seminar 10 Abbott Invited Symposium 51VT8 Multidisciplinary Treatments of Electrical Storm Invited Symposium 54Noninvasive4 Sudden Cardiac Death: Novel or Alternative Approach in Diagnosis and Therapy Invited Symposium 568 Programming of Pacemaker and ICD Lecture 4 Atrial Selective Sodium Channel Blockers for the Management of Atrial Fibrillation 1 Oral Presentation 45 Allied-3 Japanese SessionChinese Session 18:00-18:30 APHRS Annual General Meeting

3 Saturday, September 16 7:00 8:00 9:00 10:00 11:00 12:00 12:40 13:00 13:30 14:00 15:00 15:30 16:00 16:30 17:00 17:30 18:00 The 6th Antiarrhythmic Therapy Summit The Importance of Durable PVI in AF Ablation Strategies Core Curriculum Session 3 Ablation of Complex Cases: Ask the Legend Koshichiro Hirosawa Memorial Lecture Catheter Ablation of Accessory AV Pathways Invited Symposium 58AF10 Catheter Ablation of Atrial Arrhythmogenic Substrate in Atrial Fibrillation Invited Symposium 59SCD7 Fifteen years from MADIT-II and SCDHeFT: Gap between the Historical Evidence and Therapeutic Development (PCI for Acute Coronary Syndrome, CRT, New Anti-Heart Failure Drugs) Invited Symposium 60 SCD8 New Insights of Out-of-Hospital Cardiac Arrest Luncheon Seminar 17 Teatime Seminar 7 ( / ) Invited Symposium 61AF11 Target and Endpoint of AF Ablation Invited Symposium 62AF12 Current Perspective of Lazor and Hot Balloon Ablation for Atrial Fibrillation Luncheon Seminar 18 Invited Symposium 63 Pharmacological Therapy5 Rate Control of Atrial Fibrillation (Associated with Heat Failure) Invited Symposium 64 Pharmacological Therapy6 Treatment of Atrial Fibrillation by Class III Antiarrhythmic Drug APHRSWSA Joint Session Prediction and Prevention of SCD Oral Presentation 49 Allied4 General Symposium 7 How to Use Remote Monitoring Invited Symposium 68Pediatric3 Antiarrhythmic Agents for Refractory Tachyarrhythmia in Pediatric Cardiology Patients (Including Adult Congenital Heart Disease) Invited Symposium 65 Basic/Genetic9 Arrhythmia Mechanism Including Ca2+ Handling/Optical Mapping Electrocardiology Frontiers 2017 Basic and Clinical in the KATP Channel Oral Presentation 50 Allied5 General Symposium 9 Non-Pharmacotherapy for Cardiac Arrhythmias in Pediatric Patients 9:30 10:30 11:30 Oral Presentation 51 Allied6 Luncheon Seminar 19 Bristol-Myers Squibb Pfizer JAPAN Inc. Luncheon Seminar 20 Luncheon Seminar 21 DVx Inc. Luncheon Seminar 22 Co,. General Symposium 8 Regenerative Medicine and Arrhythmias Teatime Seminar 8 Teatime Seminar 9 St. Jude Medical Japan 1 Oral Presentation 46 SVT6 Allied Professional Program 3-2 Invited Symposium 66Basic/Genetic10 Sodium Channel Diseases 12th Tawara-Aschoff Symposium APHRS Young Investigator Award Competition 1 Clinical StepUp Session 1 Recently Joining Countries to APHRS Oral Presentation 47 Inherit2 Allied Professional Program 4 EP Study and Catheter Ablation-2 Oral Presentation 48 Diagnostic1 Invited Symposium 67Basic/Genetic11 ips Cells in Arrhythmia Research Sponsored Session APHRS Young Investigator Award Competition 2 Basic StepUp Session 2 New Member Countries of APHRS Oral Presentation 52 Allied7 417 Oral Presentation 53 Brady4 Oral Presentation 54 Pharm4 Oral Presentation 55 VT5 Luncheon Seminar 23 Fukuda Denshi Oral Presentation 56 Basic4 Oral Presentation 57 Basic5 Oral Presentation 58 Lead2 Oral Presentation 59 Pharm5 Oral Presentation 60 AF8 Oral Presentation 61 CRT3 Oral Presentation 62 AF9 Luncheon Seminar 24 TOA EIYO LTD. Featured Research Session 3 Oral Presentation 63 Tachy2 Oral Presentation 64 VT6 Oral Presentation 65 Inherit3 Nice 512 Morning Seminar 3 Oral Presentation 67 SVT4 Seminar 11 Nippon Boehringer Ingelheim Co,. Lecture 5 New Technologies of Catheter Ablation of Ventricular Tachycardia Sponsored Academia Session 7 Invited Symposium 71SVT4 Management of at Following AF-Ablation Oral Presentation 68 Comp1 Tea Time Seminar 13 Oral Presentation 66 SVT5 Oral Presentation 69 Pediatric2 Invited Symposium 72VT9 Chemical Ablation for VT Luncheon Seminar 25 Century Medical, Inc. Luncheon Seminar 26 ONO PHARMACEUTICAL CO., LTD. Luncheon Seminar 27 St. Jude Medical Japan JHRSCDR Luncheon Seminar 28 3 Great Debate 2 9:10 Occlusion of the Left Atrial Appendage is Preferable to Anticoagulation to Prevent Stroke in Atrial Fibrillation Patients Great Debate 3 Does Patient with Ischemic Heart Disease and Afib Require 'Triple Therapy'? Lecture 6 Tips in Programming of ICD and CRT 7 3 Luncheon Seminar 29 Luncheon Seminar 16 St. Jude Medical Japan Luncheon Seminar 30 St. Jude Medical Japan Seminar 12 Bristol-Myers SquibbPfizer JAPAN Inc. Invited Symposium 69Basic/Genetic12 Pharmacological Management of Arrhythmias Oral Presentation 70 Lead1 Invited Symposium 739 Update for MRI Examination in Patients with CIEDs JHRS-HRS Joint Session Catheter Ablation of Complex Venticular Tachyarrhythmias Oral Presentation 73 AF10 4 Seminar 13 Japan Lifeline 1 1 Oral PresentationJO76 AF3 Teatime Seminar 10 Oral Presentation 71 CHF2 Oral PresentationJO77 VT1 Seminar 14 16:10 Invited Symposium 7410 Current Status and Management of Recalled Leads Oral Presentation 74 AF11 5 Seminar 15 Seminar 16 Johnson & Johnson Invited Symposium 70AF13 Can Catheter Ablation of Atrial Fibrillation Reduce the Incidence of Stroke? Oral PresentationJO78 Pharm3 Oral Presentation 72 SVT7 Invited Symposium 75SVT5 Thirty Year Histrory of SVT Diagnosis and Ablation Oral Presentation 75 AF12 Invited Symposium 76Basic/Genetic13 LQT/CPVT: UptoDate Great Debate 4 Primary Prevention with ICD Implantation in Non-Ischemic Cardiomyopathy Should Not be Routinely Performed Great Debate 5 Substrate-Based Ablation is Better than Electrophysiolosy Based Ablation for VT 8 4/ 18:30 Japanese SessionChinese Session

4 Sunday, September 17 7:00 8:00 8:20 9:00 9:50 10:00 11:00 11:20 12:00 12:40 13:00 13:20 14:00 14:20 14:50 15:00 15:20 16:00 16:20 16:50 17:00 18:00 Core Curriculum Session 4 Core Curriculum Session 5 World Guidelines for the Management of Atrial Fibrillation Luncheon Seminar 31 Bristol-Myers Squibb Pfizer JAPAN Inc. Invited Symposium 77SCD9 The Management of Asymptomatic Patients with Brugada Syndrome Invited Symposium 78 AF14 Chemical Ablation for Atrial Fibrillation 417 Morning Seminar 4 Japan Lifeline Co., Invited Symposium 79SCD10 Progress of Detecting Methods Invasive, Noninvasive and Imagingfor High Risk Patients with SCD Joint Session New Frontiers in Cardiac Pacing Invited Symposium 83Pediatric4 Diagnosis and Treatment for Genetic Arrhythmia in Children General Symposium 10 Anticoagulation Therapy to Prevent Embolic Strokes Oral Presentation 79 SVT8 2 Oral Presentation 84 SDC3 Oral Presentation 87 Brady5 Oral Presentation 80 VT7 Oral Presentation 85 Basic6 Oral Presentation 88 Tachy3 Invited Symposium 80SCD11 Sports and Sudden Cardiac Death APHRSPACES Joint Session Sports Allowance in Accordance with or Against to the Guidelines Crossing Against Red Light Invited Symposium 84 Basic/Genetic14 AF#2Translational Research Invited Symposium 8611 Next Stage of Remote MonitoringTransition from Management to Disease Management Oral Presentation 81 Inherit4 Oral Presentation 86 Pharm8 Oral Presentation 89 Pediatric3 Luncheon Seminar 32 Fukuda Denshi Luncheon Seminar 33 Luncheon Seminar 34 St. Jude Medical Japan Co., JHRS Young Investigator Award Competition 1 Basic JHRS Young Investigator Award Competition 2 Clinical Invited Symposium 81 Pharmacological Therapy7 Summary in the 2016 ESC Guidelines for the Management of Atrial Fibrillation: Antithrombotic Therapy, Rhythm Control, Rate Control Invited Symposium 85Basic/Genetic16 Mechanism of Cardiac Pacemaker and Bradycardia General Symposium 11 Reduction in the Radiation Exposure in Non Pharmacotherapy of Cardiac Arrhythmias Featured Research Session 4 Oral Presentation 82 AF15 9:20 10:20 14:10 15:10 Invited Symposium 88AF15 Innovation in AF Ablation Oral Presentation 90 Pharm6 Invited Symposium 82 Pharmacological Therapy8 Ethnic Difference in Efficacy and Safety of DOAC Invited Symposium 8712 Latest and Future Technologies in Cardiac Rhythm Oral Presentation 83 AF16 Great Debate 6 Which is the Optimal Ablation Target of ATOriginating from PeriAVN Region Great Debate 7 Sudden Death in Competitive Athletes can be Predicted and Prevented by a Noninvasive Risk Assessment Oral Presentation 91 Pharm7 Oral Presentation 92 AF13 Oral Presentation 93 AF14 Oral Presentation 94 CRT4 Featured Research Session 5 Oral Presentation 95 Syncope2 Oral Presentation 96 VT8 & Nice Sponsored Academia Session 8 Invited Symposium 89VT10 How to Decide Ablation Strategy Based on Each VT Substrate Seminar 17 Seminar 18 Boston Scientific Invited Symposium 90SVT6 Management of AT in the Vicinity of AV Node Luncheon Seminar 35 Luncheon Seminar 36 Bayer Yakuhin, Teatime Seminar 11 Seminar 19 Co,. Invited Symposium 91 SVT7 New Technologies for Mapping and Ablation of AT Teatime Seminar 12 Seminar 20 Invited Symposium 92 VT11 Catheter Ablation of Ventricular Tachycardia 512 Lecture 7 Percutaneous Left Atrial Appedage Closure 8 4 procedure 9 / / 11 Case Report 1 Affirm study DOAC Oral PresentationJO97 SVT2 5 VT EPS 10 8 Luncheon Seminar 37 Luncheon Seminar 38 Co,. Oral PresentationJO98 Lead1 6 3D Mapping Oral PresentationJO99 AF Case Report 2/ Oral PresentationJO100 Brady-1 7 Japanese SessionChinese Session

5 Monday, September 18 Program at a Glance Friday, September 15 9:00 10:00 11:00 12:00 13:00 14:00 15:00 16:00 Venue: Exhibition Hall C, 15:40-16:40 8:30 9:00 Chaired Poster Session CP Poster Sessions MPP All MPP sessions are conducted in Japanese only. Poster Mounting Free Poster Sessions FP RF1 Allied1 Rapid Firing Sessions RF Booth1 Booth2 RF7 1 Pathology specimen Display 417 9:30 9:40 CP1 Allied1 10:00 10:30 11:00 11:30 12:00 12:30 13:00 13:30 13:50 14:00 CP2 Basic1 CP3 SVT CP4 VT1 11:10 MPP1 1 FP1 RF2 Allied2 RF3 AF1 Free poster presenters are expected stand ready in front of their poster panels during the scheduled discussion time and to have discussions with other participants in English or Japanese. There will be NO presentations initiated by session chair. 14:20 MPP2 2 RF4 AF2 RF8 Pharm1 RF9 VT/VF/VPC1 RF10 HF 1 Seminar 1 Anatomy of Aortic Root and Its Surroundings 2 HB Pathology-specimen Display 512 Japanese Session ICD/CRT ( ) Luncheon Seminar 39 Asahi Kasei Zoll Medical ICD/CRT ( ) 15:00 15:30 16:00 14:50 MPP3 3 15:20 RF5 VT/VF/VPC2 RF6 Inherited RF11 SVT RF12 2 Seminar 2 Anatomy of AV JunctionAV Node and His Bundleand Its Surroundings: Potentialities of His Bundle Pacing from the View Point of Anatomy 16:30 17:00 Poster Removal 17:30

6 Saturday, September 16 Program at a Glance Sunday, September 17 Venue: Exhibition Hall C, Venue: Exhibition Hall C, Poster Sessions Poster Sessions Chaired Poster Sessions CP MPP Free Poster Sessions FP Rapid Firing Sessions RF Pathology specimen Display Chaired Poster Sessions CP Free Poster Sessions FP Rapid Firing Sessions RF Pathology specimen Display 8:30 Poster Mounting Booth1 RF13 Pharm2 Booth2 RF19 AF3 8:30 Poster Mounting Booth1 RF25 AF8 Booth2 RF30 VT/VF/VPC5 9:00 9:10 CP5 AF1 9:30 10:00 10:30 10:40 11:00 CP7Pharm1 MPP4 4 9:45 MPP5 Clinical Research/Teaching Case Reports1 10:15 MPP6 Clinical Research/Teaching Case Reports2 10:40 RF14 Allied3 RF15 AF5 RF20 AF4 RF Seminar 3 Structure of RA and RV: Including Normal Conduction System in RV 9:00 9:10 CP9 AF2 9:30 10:00 10:30 10:40 11:00 CP11 Ablation & Noninvasive RF26 Allied4 RF27 AF10 RF31 AF9 RF Purkinje Seminar 5 Anatomy of LV and Pericardial/ Pleural Cavity: LV Papillary Muscles and Normal Conduction System in LV, Possible Mechanism of Conduction System between LV Anterolateral and Posteromedial Papillary Muscles Pathology-specimen Display 11:30 12:00 12:30 13:00 13:30 13:50 14:00 CP6 15:00 15:30 16:00 Free poster presenters are expected stand ready in front of their poster panels during the scheduled discussion time and to have discussions with other participants in English or Japanese. There will be NO presentations initiated by session chair. CP8 Pharm & Inherited FP2 MPP7 5/ 14:20 MPP8 1/ 14:50 MPP9 2/Case Report 15:25 RF16 SCD RF17 Ped1 RF18 VT/VF/VPC3 RF22 AF6 RF23 Pharm3 RF24 AF7 4 Seminar 4 Structure of LA and Its SurroundingsIncluding Pulmonary Veins and Artery, Aorta, Esophagus, Sinus Node Artery, His Bundle and Phrenic Nerves Pathology-specimen Display 11:30 12:00 12:30 13:00 13:30 CP10 CP12 14:00 Teaching Cases Basic & 15:00 15:10 15:30 16:00 Free poster presenters are expected stand ready in front of their poster panels during the scheduled discussion time and to have discussions with other participants in English or Japanese. There will be NO presentations initiated by session chair. FP3 15:20 RF28 Pediatric2 RF29 AF11 RF33 Pharm4 16:30 Poster Removal 16:30 Poster Removal 17:00 17:00 17:30 17:30 Japanese Session Japanese Session